178 related articles for article (PubMed ID: 12392761)
1. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
[TBL] [Abstract][Full Text] [Related]
2. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD; Malfait AM; Deccico C; Arner E
Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
[TBL] [Abstract][Full Text] [Related]
5. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
6. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).
Tortorella MD; Pratta M; Liu RQ; Austin J; Ross OH; Abbaszade I; Burn T; Arner E
J Biol Chem; 2000 Jun; 275(24):18566-73. PubMed ID: 10751421
[TBL] [Abstract][Full Text] [Related]
7. Truncation of the amino-terminus of the recombinant aggrecan rAgg1mut leads to reduced cleavage at the aggrecanase site. Efficient aggrecanase catabolism may depend on multiple substrate interactions.
Hörber C; Büttner FH; Kern C; Schmiedeknecht G; Bartnik E
Matrix Biol; 2000 Nov; 19(6):533-43. PubMed ID: 11068207
[TBL] [Abstract][Full Text] [Related]
8. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
9. Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein.
Pratta MA; Scherle PA; Yang G; Liu RQ; Newton RC
Arthritis Rheum; 2003 Jan; 48(1):119-33. PubMed ID: 12528112
[TBL] [Abstract][Full Text] [Related]
10. TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5).
Kashiwagi M; Tortorella M; Nagase H; Brew K
J Biol Chem; 2001 Apr; 276(16):12501-4. PubMed ID: 11278243
[TBL] [Abstract][Full Text] [Related]
11. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
[TBL] [Abstract][Full Text] [Related]
12. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
Kashiwagi M; Enghild JJ; Gendron C; Hughes C; Caterson B; Itoh Y; Nagase H
J Biol Chem; 2004 Mar; 279(11):10109-19. PubMed ID: 14662755
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
14. Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.
De Savi C; Pape A; Sawyer Y; Milne D; Davies C; Cumming JG; Ting A; Lamont S; Smith PD; Tart J; Page K; Moore P
Bioorg Med Chem Lett; 2011 Jun; 21(11):3301-6. PubMed ID: 21536437
[TBL] [Abstract][Full Text] [Related]
15. An aggrecanase and osteoarthritis.
Karsenty G
N Engl J Med; 2005 Aug; 353(5):522-3. PubMed ID: 16079379
[No Abstract] [Full Text] [Related]
16. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
Tortorella MD; Pratta MA; Fox JW; Arner EC
J Biol Chem; 1998 Mar; 273(10):5846-50. PubMed ID: 9488721
[TBL] [Abstract][Full Text] [Related]
17. [Role of aggrecanase and MMP in cartilage degradation].
Ishiguro N; Kojima T
Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
[TBL] [Abstract][Full Text] [Related]
18. The cleavage of biglycan by aggrecanases.
Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
[TBL] [Abstract][Full Text] [Related]
19. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
[TBL] [Abstract][Full Text] [Related]
20. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins.
Tortorella MD; Burn TC; Pratta MA; Abbaszade I; Hollis JM; Liu R; Rosenfeld SA; Copeland RA; Decicco CP; Wynn R; Rockwell A; Yang F; Duke JL; Solomon K; George H; Bruckner R; Nagase H; Itoh Y; Ellis DM; Ross H; Wiswall BH; Murphy K; Hillman MC; Hollis GF; Newton RC; Magolda RL; Trzaskos JM; Arner EC
Science; 1999 Jun; 284(5420):1664-6. PubMed ID: 10356395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
